Latest stories

  • in

    Higher-dose corticosteroids raise mortality risk by 60 percent in low-oxygen COVID patients: Lancet

    Higher-dose corticosteroids raise mortality risk by 60 percent in low-oxygen COVID patients: Lancet

    UK: Higher dose corticosteroids compared with standard dose corticosteroids increase mortality for patients with COVID-19 and hypoxia who are not receiving invasive or non-invasive mechanical ventilation, findings from a large, randomised trial have shown.  The study found that compared with standard care that included low-dose corticosteroid use, treating hypoxic COVID-19 patients needing only oxygen therapy […] More

  • in

    Endovascular treatment safe for late-presenting stroke patients with collateral flow: Lancet

    Endovascular treatment safe for late-presenting stroke patients with collateral flow: Lancet

    Netherlands: A new study conducted in the Netherlands has found that endovascular treatment for anterior circulation ischaemic stroke is effective and safe within a 6 to 24-hour window, according to research published in The Lancet.  The study, called MR CLEAN-LATE, aimed to assess the efficacy and safety of endovascular treatment for patients treated in the […] More

  • in

    Sodium bicarbonate for metabolic acidosis in transplant patients does not alter GFR: Lancet

    Management of metabolic acidosis with sodium bicarbonate therapy over a two-year period in adult kidney transplant patients had no impact on the fall in estimated glomerular filtration rate (GFR), says an article published in The Lancet. In kidney transplant patients, metabolic acidosis is frequent and is linked to deteriorating graft function. While sodium bicarbonate therapy […] More